Restricted accessResearch articleFirst published online 2014-01
Inability to Detect Human T Cell Lymphotropic Virus Type 2-Specific Antibodies in a Patient Coinfected with HIV-1,Human T Cell Lymphotropic Virus Type 1,Human T Cell Lymphotropic Virus Type 2,and Hepatitis C Virus
HIV-1, human T cell lymphotropic virus type 1 and type 2 (HTLV-1 and HTLV-2) and hepatitis C virus (HCV) are common among intravenous drug users (IDUs) and can cause chronic infections in the host. Usually, the diagnosis of such viruses employs serological assays; however, some difficulties in confirming HTLV-2 infection have been reported in high-risk populations in Brazil. We present data of an unusual case of coinfection with HIV-1, HTLV-1, HTLV-2, and HCV in a male IDU in which HTLV-2 was detected only by molecular assays. Comparative analysis of retroviruses from 2002 and 2012 showed identical HTLV-1 and HTLV-2 sequences (LTR, env, and tax), and a change in HIV-1 tropism from CXCR4 to CCR5. No mutation was detected in the hot points of the env region of the HTLV-2 isolate that justified the lack of rgp46-II-specific antibodies. These data emphasize the need for molecular assays to diagnose HTLV-2 in high-risk populations in Brazil.
Get full access to this article
View all access options for this article.
References
1.
UNAIDS: Global Report–UNAIDS report for the global Aids epidemic, 2010. Available at www.unaids.org/globalreport/HIV_prevalence_map.htm. Accessed January19, 2012.
2.
ProiettiFA, Carneiro-ProiettiABF, Cataln-SoaresBC, and MurphyEL: Global epidemiology of HTLV-1 infection and associated diseases. Oncogene, 2005; 24:6058–6068.
3.
Catalan-SoaresB, Carneiro-ProiettiABF, ProiettiFA, and the Interdisciplinary HTLV Research Group: Heterogeneous geographic distribution of human T-cell lymphotropic viruses I and II (HTLV-I/II): Serological screening prevalence rates in blood donors from large urban areas in Brazil. Cad Saúde Púb (RJ), 2005; 21:926–931.
4.
DouradoI, AlcantaraLC, BarretoML, TeixeiraMG, and Galvão-CastroB: HTLV-I in the general population of Salvador, Brazil: A city with African ethnic and sociodemographic characteristics. J Acquir Immune Defic Syndr, 2003; 34:527–531.
5.
IshakR, VallinotoACR, AzevedoVN, and IshakMQ: Epidemiological aspects of retrovirus (HTLV) infection among Indian populations in the Amazon Region of Brazil. Cad Saúde Púb (RJ), 2003; 19:901–914.
6.
GabbaiAA, BordiniJO, Vieira-FilhoJPB, et al.: Selectivity of human T lymphotropic vírus type-1 (HTLV-1) and HTLV-2 infection among different populations in Brazil. Am J Trop Med Hyg, 1993; 49:664–671.
7.
MartinsT, Narciso-SchiavonJL, and SchiavonLL: Epidemiology of hepatitis C virus infection. Rev Assoc Med Bras, 2011; 57:105–110.
8.
BeilkeMA: Retroviral coinfections: HIV and HTLV: Taking stock of more than a quarter century of research. AIDS Res Hum Retroviruses, 2012; 28:139–147.
9.
BritesC, SampaioJ, and OliveiraA: HIV/Human T-cell lymphotropic virus coinfection revisited: Impact on AIDS progression. AIDS Rev, 2009; 11:8–16.
10.
BahiaF, NovaisV, EvansJ, et al.: The impact of human T-cell lymphotropic virus 1 infection on clinical and immunologic outcomes in patients coinfected with HIV and hepatitis C virus. J Acquir Immune Defic Syndr, 2011; 57(Suppl 3):S202–S207.
11.
MorimotoHK, MorimotoAA, ReicheEMV, et al.: Difficulties in the diagnosis of HTLV-2 infection in HIV/AIDS patients from Brazil. Comparative performances of serologic and molecular assays, and detection of HTLV-2b subtype. Rev Inst Med Trop S. Paulo, 2007; 49:225–230.
12.
JacobF, Santos-FortunaE, AzevedoRS, and Caterino-de-AraujoA: Serological patterns for HTLV-I/II and its temporal trend in high-risk populations attended at Public Health Units of São Paulo, Brazil. J Clin Virol, 2008; 42(2):149–155.
13.
MagriMC, BrigidoLFM, RodriguesR, MorimotoHK, FerreiraJLP, and Caterino-de-AraujoA: Phylogenetic and similarity analysis of HTLV-1 isolates from HIV-coinfected patients from the South and Southeast regions of Brazil. AIDS Res Hum Retroviruses, 2012; 28:110–114.
14.
MagriMC, BrigidoLFM, RodriguesR, MorimotoHK, FerreiraJLP, and Caterino-de-AraujoA: Tax gene characterization of HTLV-1 strains from Brazilian HIV-coinfected patients. AIDS Res Hum Retroviruses, 2012; 28:1775–1778.
15.
MagriMC, BrigidoLFM, MorimotoHK, and Caterino-de-AraujoA: HTLV type 2a strains among HIV-1-coinfected patients from Brazil have originated mostly from Brazilian Amerindians. AIDS Res Hum Retroviruses, 2013; 29(7):1010–1018.
16.
LipkaJJ, MiyoshiI, HadlockKG, et al.: Segregation of human T cell lymphotropic virus type I and II infections by antibody reactivity to unique viral epitopes. J Infect Dis, 1992; 165:268–272.
17.
OlahI, FukumoriLMI, SmidJ, Penalva de OliveiraAC, DuarteAJS, and CassebJ: Neither molecular diversity of envelope, immunosuppression status, nor proviral load causes indeterminate HTLV Western blot profiles in samples from human T-cell lymphotropic virus type 2 (HTLV-2)-infected individuals. J Med Virol, 2010; 82:837–842.
18.
BrigidoLFM, FrancoHM, CustódioRM, et al.: Molecular characteristics of HIV type 1 circulating in São Paulo, Brazil. AIDS Res Hum Retroviruses, 2005; 21:673–682.
19.
FerreiraJL, CoelhoLP, RodriguesR, et al.: Evaluation of genotypic prediction of HIV-1 tropism using population sequencing of replicates. J Virol Methods, 2012; 179:325–329.
